{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-077089","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.282443+00:00","generated_at":"2026-05-20T14:32:41.142068+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aptevo Therapeutics effects 1-for-20 reverse stock split effective May 23, 2025","bullets":["Stockholders approved reverse split 1:6 to 1:20 at May 14 special meeting; board chose 1:20 on May 21.","Filed Certificate of Amendment effective 5:01 PM ET May 23; shares trade split-adjusted from May 27.","No fractional shares issued; cash payment in lieu for stockholders; warrants rounded up to whole share.","New CUSIP 03835L 504; par value remains $0.001 per share; adjustments to options, RSUs, warrants.","Reverse split reduces outstanding shares proportionately, no change in percentage ownership for stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-077089","json":"https://secwatch.observer/filing/0000950170-25-077089.json","markdown":"https://secwatch.observer/filing/0000950170-25-077089.md","text":"https://secwatch.observer/filing/0000950170-25-077089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025077089/0000950170-25-077089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025077089/apvo-20250523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T14:32:41.142068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7c08db4c0000c557df2a48e8cff635221bdb6f31","claim":"Aptevo Therapeutics Inc.: Amended certificate of incorporation to effect a 1-for-20 reverse stock split of common stock, filed and effective May 23, 2025 (effective 2025-05-23).","evidence_excerpt":"On May 21, 2025, the Board approved an amendment to the Certificate of Incorporation to effect a reverse stock split of its common stock at the reverse split ratio of 1-for-20 (the “Reverse Stock Split”). Accordingly, on May 23, 2025, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect the Reverse Stock Split. The Amendment was effective at 5:01 p.m. Eastern Time on May 23, 2025 (the “Effective Time”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025077089/0000950170-25-077089-index.htm","confidence":0.99,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-23"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}